World’s first experience treating TASC II C and D tibial occlusive disease using the Selution SLR Sirolimus-Eluting Balloon: six-month results from the PRESTIGE study - Tang, TY; Yap, C; Soon, SXY (J Endovasc Ther, 2021)
et al.